Prescription drugs; price transparency. (HB876)
Introduced By
Sen. Suhas Subramanyam (D-Ashburn)
Progress
✓ |
Introduced |
✗ |
Passed Committee |
☐ |
Passed House |
☐ |
Passed Senate |
☐ |
Signed by Governor |
☐ |
Became Law |
Description
Prescription drug price transparency. Requires every health carrier, pharmacy benefits manager, wholesale drug distributer, and drug manufacturer to report information about prescription drug prices and related information to the Department of Health and requires the Department to make such information available on its website. Read the Bill »
Status
12/04/2020: Failed to Pass in Committee
History
Date | Action |
---|---|
01/07/2020 | Prefiled and ordered printed; offered 01/08/20 20104912D |
01/07/2020 | Referred to Committee on Health, Welfare and Institutions |
01/17/2020 | Assigned HWI sub: Health Professions |
01/29/2020 | Impact statement from DPB (HB876) |
01/30/2020 | House committee, floor amendments and substitutes offered |
01/30/2020 | Subcommittee recommends continuing to 2021 |
02/04/2020 | Continued to 2021 with substitute in Health, Welfare and Institutions |
12/04/2020 | Left in Health, Welfare and Institutions |